Type | Indexed | Publication . Mgi Jnum | J:263206 |
Publication . Citation | Weng Y, et al. (2018) Glyco-engineered Long Acting FGF21 Variant with Optimal Pharmaceutical and Pharmacokinetic Properties to Enable Weekly to Twice Monthly Subcutaneous Dosing. Sci Rep 8(1):4241 |